2Rodrigues CA,Chauffaille ML,Pelloso LA,et al.Acute myeloid leukemia in elderly patients:experience of a single center[J].Braz J Med Biol Res,2003 ;36(6):703-8.
3Grimwade D,Walker H,Harrison G,et al.The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML):analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial[J].Blood,2001 ;98(5):1312-20.
4Leith CP,Kopecky K J,Godwin J,et al.Acute myeloid leukemia in the elderly:assessment of multidrug resistance (MDR1) and cytogeneticsdistinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy.A Southwest Oncology Group Study[J].Blood,1997;89(9):3323-9.
5Gajewski JL,Ho WG,Nimer SD,et al.Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome[J].J Clin Oncol,1989;7(11):1637-45.
7Pinto A,Zagonel V,Ferrara F.Acute myeloid leukemia in the elderly:biology and therapeutic strategies[J].Crit Rev Oncol Hematol,2001;39(3):275-87.
8Sekeres MA,Stone RM.The challenge of acute myeloid leukemia in older patients[J].Curr Opin Oncol,2002;14(1):24-30.
9Schrich M,Illmer T,Aulitzky W,et al.Intensified double induction therapy with high dose mitoxantrone,etoposide,mamsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years[J].Haematologica,2002 ;87 (8):808-15.
10Anderson JE,Kopechy KJ,Willman Cl,et al.Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin:a Southwest Oncology Group Study[J].Blood,2002;100(12):3869-76.
10Bumett AK,Russell NH,Kell J,et al.European development of clofara-bine as treatment for older patients with acute myeloid leukemia consid-ered unsuitable for intensive chemotherapy[J].J Clin Oncol, 2010; 28(14):2389-95.
